Multiple endocrine neoplasia: Difference between revisions
(Created page with "==Background== ==Clinical Features== ==Differential Diagnosis== ==Evaluation== ===Workup=== ===Diagnosis=== ==Management== ==Disposition== ==See Also== ==External Links== ==References== <references/>") |
|||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Autosomal dominant predisposition to tumors within endocrine organs/glands | |||
*Classified into two distinct syndromes, multiple endocrine neoplasia type 1 (MEN1), and multiple endocrine neoplasia type 2 (MEN2) | |||
**Type 2 further subclassified into MEN2A and MEN2B | |||
==Clinical Features== | ==Clinical Features== | ||
Revision as of 22:39, 13 December 2022
Background
- Autosomal dominant predisposition to tumors within endocrine organs/glands
- Classified into two distinct syndromes, multiple endocrine neoplasia type 1 (MEN1), and multiple endocrine neoplasia type 2 (MEN2)
- Type 2 further subclassified into MEN2A and MEN2B